Promising Treatments For Blood Cancers Presented By JT Cancer Center Researchers At ASH Meeting
12/28/2011
Researchers from the John Theurer Cancer Center at Hackensack University Medical Center, one of the nation's top 50 best hospitals for cancer, presented results from 31 major studies of blood-related cancers - leukemia, lymphoma and multiple myeloma -- during the American Society of Hematology (ASH) Annual Meeting, December 10-13, 2011 in San Diego...
Hide And Seek Signals In The Immune System
12/28/2011
The white blood cells that fight disease and help our bodies heal are directed to sites of infection or injury by 'exit signs' - chemical signals that tell them where to pass through the blood vessel walls and into the underlying tissue...
ORNL Image Analysis Prowess Advances Retina Research
12/27/2011
Armed with a new ability to find retinal anomalies at the cellular level, neurobiologists at St. Jude Children's Research Hospital have made a discovery they hope will ultimately lead to a treatment for cancer of the retina. While much work remains, Oak Ridge National Laboratory's specialized tracing algorithm allows researchers to analyze thousands of cells instead of just a few dozen...
Bevacizumab Reduces Nasopharyngeal Carcinoma Spread - Trial Finds
12/27/2011
According to a new phase 2 trial published Online First in The Lancet Oncology, the combination of the widely used anti-cancer drug bevacizumab with standard chemo-radiation therapy is safe, and could prolong survival in patients with advanced nasopharyngeal carcinoma, without any apparent increased adverse side effects...
Fixing Common Blood Disorder Would Make Kidney Transplants More Successful
12/27/2011
Correcting anemia, a red blood cell deficiency, can preserve kidney function in many kidney transplant recipients, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN). The results indicate that aggressively treating anemia may help save the kidneys and possibly the lives of many transplant recipients...
Restricting Post-Surgery Blood Transfusion Is Safe For Some Hip Patients
12/27/2011
More than half of the older, anemic patients in a New England Journal of Medicine study did not need blood transfusions as they recovered from hip surgery, according to new research co-authored by University of Maryland School of Medicine scientists. The findings could immediately change the way such patients are treated...
Angina Medication May Be Effective For Managing Certain Cancers, Study Finds
12/26/2011
Researchers at Queen's University have identified a new mechanism that could potentially explain why the body's immune system sometimes fails to eliminate cancer...
Thousands Of Lives Could Be Saved By Simple Test To Help Diagnose Bowel And Pancreatic Cancer
12/26/2011
A simple online calculator could offer family GPs a powerful new tool in tackling two of the most deadly forms of cancer, say researchers...
Bevacizumab Reduces Nasopharyngeal Carcinoma Spread - Trial Finds
12/26/2011
According to a new phase 2 trial published Online First in The Lancet Oncology, the combination of the widely used anti-cancer drug bevacizumab with standard chemo-radiation therapy is safe, and could prolong survival in patients with advanced nasopharyngeal carcinoma, without any apparent increased adverse side effects...
KS-Herpesvirus Induces Reprogramming Of Lymphatic Endothelial Cells To Invasive Mesenchymal Cells
12/26/2011
Human tumor viruses contribute to 15-20% of human cancers worldwide. Kaposi's sarcoma herpesvirus (KSHV) is an etiological agent for Kaposi's sarcoma (KS) and two other rare lymphoproliferative malignancies. KS is the most common cancer in HIV-infected untreated individuals and remains a primary cause of cancer deaths in many subequatorial African countries as a result of the AIDS pandemic...